Delivery Order SPE2DX22D0010-SPE2D826FAR21
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,376.94 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the supply of Vyvanse 60 mg capsules. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of September 17, 2025, and will be performed at the company's Conshohocken facility. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,783.60 on May 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) by the Defense Logistics Agency. This contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement with an ultimate completion date of May 14, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $12,936 firm fixed price delivery order for Vyvanse Caps 30mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 30, 2025, for the supply of Vyvanse capsules (50mg) valued at $62,080.74. The contract is a firm fixed price delivery order with an ultimate completion date of July 1, 2025, and represents a non-competitive set-aside award issued by the Defense Logistics Agency's Medical Supply Chain. The place of performance is AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Vyvanse 60 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $1,946.30. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by April 25, 2025. This delivery order represents a continuation of AmerisourceBergen's role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,904.90 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, for the supply of Vyvanse 30 milligram capsules (100 count). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was competitively awarded without set-aside designation. This award falls under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,377.46 by the Defense Logistics Agency on September 22, 2025, for the supply of Vyvanse 50 mg capsules (100 count). The award, which is not set-aside and employs firm fixed price terms, represents a single delivery order under a larger contract vehicle. This order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for Vyvanse 20 mg capsules (100 count) with a ceiling value of $9,282.09. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 5, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for the supply of Vyvanse capsules, 30 milligram strength, with a contract ceiling value of $53,073.05. The award, issued on September 22, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025. This non-competitive set-aside contract represents a single delivery transaction under AmerisourceBergen's broader relationship with the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $26,490.27 by the Medical Supply Chain, a defense-focused federal agency, on September 17, 2025. The contract, which is set to be completed by September 18, 2025, covers the supply of Vyvanse capsules (50mg), a prescription medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. This...